Labcorp reported first-quarter revenues of $3.54 billion, up 5.8% year on year, but delivered the weakest performance against analyst estimates, the slowest revenue growth, and the weakest full-year guidance update among five tracked testing and diagnostics services stocks. The group as a whole beat consensus revenue estimates by 3.2%, with Guardant Health leading on a 48.3% revenue surge to $301.7 million and the biggest guidance raise. RadNet grew revenues 22.1% to $575.6 million but missed EPS estimates significantly, while NeoGenomics and Quest Diagnostics also exceeded revenue expectations. Share prices across the group have risen 20.3% on average since reporting.
Laboratory Corporation of America HoldingsLabcorp reported the weakest Q1 revenue growth, analyst estimate miss, and weakest full-year guidance among peers.
Quest Diagnostics Incorporated
Guardant Health Inc
NeoGenomics Inc
RadNet Inc